Navigation Links
Catheter Ablation Effective in Treating Atrial Fibrillation
Date:5/14/2009

Burning faulty tissue better than meds for irregular heartbeat, study suggests

THURSDAY, May 14 (HealthDay News) -- Treating an irregular heartbeat by searing faulty heart tissue may be more effective than treating with medication, a new study shows.

Nearly two-thirds of study participants with atrial fibrillation experienced no such condition-related symptoms one year after having a catheter ablation, a procedure in which heart tissue responsible for the erratic electrical signals throwing off the organ's pumping rhythm is burned and destroyed. Only 17 percent of those in the study treated for the condition with medications reported being arrhythmia-free in the same period.

Those who had the surgical procedure also said they experienced a great improvement in their quality of life.

The international study's 167 participants, all of whom had previously been unable to control the condition with medication alone, had been randomly assigned to either have the heart procedure or be treated for it with medications, according to the research, lead by Dr. David Wilber, director of the Cardiovascular Institute at Loyola University Stritch School of Medicine, in Maywood, Ill.

Wilber was scheduled to present his team's findings Thursday at the Heart Rhythm Society's annual meeting in Boston. The study was funded by Biosense Webster, maker of the ThermoCool catheter used in the trial, and Wilber is a consultant to the company.

More than 2 million Americans have atrial fibrillation, making it the most common of heart rhythm disorders. The electrical signals to the heart become irregular, causing the organ's upper chambers to pump out of rhythm. The condition can cause heart palpitations, dizziness, fatigue, shortness of breath and fainting that lead to a person having a lack of energy, feeling of weakness and a poor quality of life. It can also lead to stroke and heart failure.

Doctors often first prescribe beta blockers, calcium channel blockers, flecainide or propafenone to try to improve the condition before resorting to surgical options such as installing a pacemaker or catheter ablation.

In catheter ablation, doctors guide a thin flexible tube through blood vessels to the heart. Radiofrequency energy directed from the tube's tip heats and destroys the tissue causing the bad electrical signals. The procedure's risks include creating fluid in the lungs or around the heart, bleeding, clots and stroke.

Another study, involving about 3,000 atrial fibrillation patients who will be followed for three years, will try to determine whether those who have catheter ablation live longer those using medication for the condition, according to background information in a Loyola University news release on the study.

More information

The American Heart Association has more about atrial fibrillation.



-- Kevin McKeever



SOURCE: Loyola University Health System, news release, May 14, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. NYC-area 1st: Morgan Stanley Childrens Hospital performs transcatheter pulmonary valve replacement
2. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
3. Catheter angiography may be an unnecessary follow-up to CT angiography
4. Massive necrosis after trans-catheter treatment is more common in the presence of tumor capsule
5. Catheter chaos: Hospitals lag in preventing common infection
6. Nerites Receives NIH Grant to Study Novel Treatment for Preventing Dangerous Bacterial Infections on Urinary Stents and Catheters
7. Balloon catheter-based sinus surgery radiation exposure very low, safe
8. St. Davids Medical Center First in Texas to Implement Visually Guided Catheter Ablation for Atrial Fibrillation
9. Led by Cardiovascular Applications, Double Digit Growth Expected for Catheter Sales
10. Catheter repair of mitral valve improves heart size, symptoms
11. Verathon(R) Offers Enhanced BladderScan(R) Instrument as Part of Continued Program to Eliminate Unnecessary Catheterizations, Decrease Urinary Tract Infections and Assist in Hospital Infection Control
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Catheter Ablation Effective in Treating Atrial Fibrillation
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated ... in breathing. Oral appliances can offer significant relief to about 75 percent of ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... ... , ... The American College of Medical Informatics (ACMI) will present the 2017 ... Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is ... pioneer in the field of medical informatics, this prestigious award is presented to an ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a ... of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners ... October 11, 2017. , The annual award competition recognizes editorial and design excellence across ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, ... formed by Walgreens and pharmacy benefit manager Prime Therapeutics ... new brand, which included the unveiling of new signage ... , as well as at a few other company-owned ... new brand to patients, some of whom will begin ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, Inc. ... earnings conference call and webcast on Friday, November 3, ... (EDT) and ending at approximately 8:30 a.m. (CDT) / ... the company,s 2017 financial performance and guidance for 2018, ... initiatives to enhance operational performance, and long-range financial outlook ...
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017 /PRNewswire/ ... health and big data solutions, today announced that its MyDario product is ... your local TV listings for when The Dr. Oz Show airs in ... The nine-time ... month. ...
Breaking Medicine Technology: